| Literature DB >> 29922529 |
Ambika Anand1, Courtney Wagner1, Steve S Kong1, Elliot Griffith1, Punnavit Harimtepathip1, Kathryn K Baker1, Stephen Rineer1, Judith Simms-Cendan1, Magdalena Pasarica2.
Abstract
Introduction Latent tuberculosis infection (LTBI) screening with targeted treatment has been successful in eradicating tuberculosis (TB) as an endemic infection in the United States. The Centers for Disease Control and Prevention (CDC) recommends screening for high-risk patients. The aim of this study was to increase LTBI screening, detection, and treatment in our student-run free clinic while providing an innovative platform for education in primary care topics. Methods A questionnaire for screening for LTBI was adapted from CDC guidelines. Medical students and providers received education on the screening process and administered questionnaires to patients. We analyzed the rate of performed LTBI screening, the rate of diagnostic testing for patients with positive screening, and the feasibility of implementing a preventive screening initiative. Results Fifty-two patients completed primary care visits. Forty patients were screened for LTBI. Of those screened, 42.5% were positive for the screening. Of those with positive screening, 70.6% were followed up via diagnostic testing, with the rest of them being lost for follow-up due to not attending the clinic for care. Conclusions This educational intervention combined with a screening tool was effective in increasing LTBI screening rates amongst patients in a student-run free clinic.Entities:
Keywords: ltbi; preventative medicine; screening; student-run free clinics; tuberculosis
Year: 2018 PMID: 29922529 PMCID: PMC6003801 DOI: 10.7759/cureus.2488
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Sample of LTBI screening questions adapted from CDC guidelines.
CDC: Centers for Disease Control and Prevention; LTBI: Latent tuberculosis infection; TB: Tuberculosis; HIV: Human immunodeficiency virus.
| Questions in the electronic medical record system | Answer options |
| The patient spent time with someone who has TB disease | Yes, No, Unknown |
| Has HIV infection or another medical problem that weakens the immune system | Yes, No, Unknown |
| Has symptoms of TB disease | No, fever, night sweats, cough, weight loss, other |
| Is from a country where TB disease is common | No, Latin America, Caribbean, Africa, Asia, Eastern Europe, Russia, other |
| Lives or works somewhere in the US where TB disease is more common | No, homeless shelter, prison or jail, nursing home, other |
| Uses illegal drugs | Yes, No, Unknown |
Risk factors present in our patient population.
The table shows the breakdown of risk factors found among the patients who were screened from the Latent Tuberculosis Infection (LTBI) questionnaire implemented by our student-run free clinic.
TB: Tuberculosis; PPD: Purified protein derivative; BCG: Bacillus Calmette–Guérin.
| Percentage of screened patients with associated risk factors | |
| Emigrated from endemic region | 30.0% |
| Symptoms of active TB | 10.0% |
| Recent exposure to TB | 2.5% |
| History of positive PPD or Quantiferon Gold | 7.5% |
| Diabetes mellitus | 7.5% |
| Recent travel to the endemic region | 5.0% |
| Born in foreign country | 5.0% |
| Illegal drug use | 2.5% |
| History of BCG vaccine | 5.0% |
| Immunosuppressive therapy | 2.5% |
| History of latent TB | 0.0% |
| Immunodeficiency | 0.0% |
Figure 1Diagram of screening events.
LTBI: Latent tuberculosis infection.